EDIT vs MGM · rev $32.3M vs P/E 64, rev $17.54B
Editas Medicine Inc (EDIT) versus MGM Resorts International (MGM) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
MGM Resorts International (MGM) is a resorts & casinos company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported MGM revenue for 2025-12-31 was $17.54B. Net income was $205.9M. Revenue was up 1.7% from 2024-12-31 to 2025-12-31. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
EDIT currently screens at market cap $375.2M. MGM currently screens at market cap $12.01B and trailing P/E 64.3.
Not investment advice. Open the EDIT and MGM stock pages for the full models.
Not investment advice.